Core Insights - The latest net value of ICBC Frontier Medical Stock C (010685) is 3.4160 yuan, reflecting a growth of 1.04% [1] - The fund has shown a monthly return of 3.83%, a six-month return of 28.13%, and a year-to-date return of 33.02% [1] - The fund's top ten stock holdings account for a total of 59.44%, with significant positions in companies such as Heng Rui Medicine (9.51%) and Ke Lun Pharmaceutical (9.16%) [1] Fund Performance - The fund was established on November 23, 2020, and as of June 30, 2025, it has a total scale of 1.26 billion yuan [1] - The fund manager is Zhao Bei, who has extensive experience in the healthcare sector [2] Holdings Overview - The top ten holdings include: - Heng Rui Medicine: 9.51% - Ke Lun Pharmaceutical: 9.16% - Xin Li Tai: 6.70% - Hai Si Ke: 6.02% - Bai Ji Shen Zhou-U: 5.96% - Xin Nuo Wei: 5.86% - Ze Jing Pharmaceutical-U: 4.77% - Yao Ming Kang De: 4.60% - Hua Dong Medicine: 4.57% - Rong Chang Biological: 2.29% [1]
8月21日工银前沿医疗股票C净值增长1.04%，今年来累计上涨33.02%
Sou Hu Cai Jing·2025-08-21 13:07